Physician

Konstantin Kovtun, M.D.

According to 2025 Medicare claims, Konstantin Kovtun, M.D. (NPI: 1528406832) practices radiation oncology in the Baton Rouge, LA market, with the plurality of this provider's patient population coming from E. Baton Rouge, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70809-3482. Kovtun is affiliated with the On Belay Health Solutions (ACO ID: A5260), participating under the MSSP model.

Kovtun's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 567 traditional Medicare patients, billed 38,337 HCPCS/CPT codes, and received $1,870,455 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 165 prescription claims across 98 beneficiaries totaling $2,125 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 1 records totaling $21. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $230,725 to $1,870,455. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,294 and ending at $2,125. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$935K$1.9M2018 Medicare payment: $230,725 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $408,046 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $484,057 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $438,785 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $860,174 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $961,944 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,870,455 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181692,350$230,725
20192556,569$408,046
20202468,310$484,057
20212227,411$438,785
202235419,097$860,174
202342233,596$961,944
202456738,337$1,870,455

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.1K$4.2K2015 Drug cost: $2,294 (USD; Tot_Drug_Cst)2018 Drug cost: $705 (USD; Tot_Drug_Cst)2019 Drug cost: $1,976 (USD; Tot_Drug_Cst)2020 Drug cost: $1,588 (USD; Tot_Drug_Cst)2021 Drug cost: $4,237 (USD; Tot_Drug_Cst)2022 Drug cost: $3,037 (USD; Tot_Drug_Cst)2023 Drug cost: $1,681 (USD; Tot_Drug_Cst)2024 Drug cost: $2,125 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151634$2,294
2016N/RN/RN/R
2017N/RN/RN/R
20182336$705
201958100$1,976
202057100$1,588
20214586$4,237
202264137$3,037
202369129$1,681
202498165$2,125

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session1551,028$238
77014Ct guidance for insertion of radiation therapy fields1711,009$83
77336Continuing radiation therapy consultation per week128253$60
71260Ct scan of chest with contrast121157$41
Q9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml14819,022$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl513,032$530
Memantine HclMemantine Hcl20769$476
DexamethasoneDexamethasone13390$219
LorazepamLorazepam32341$52

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$21Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Konstantin Kovtun, M.D.?

Tedicare shows public-source Medicare data for Konstantin Kovtun, M.D. (NPI 1528406832), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Konstantin Kovtun, M.D. have ACO affiliation data?

Konstantin Kovtun, M.D. is shown with ACO affiliation data for On Belay Health Solutions (MSSP, ACO ID A5260).

What billing organization is linked to Konstantin Kovtun, M.D.?

Konstantin Kovtun, M.D. is linked to MARY BIRD PERKINS CANCER CENTER (billing NPI 1295833580) in the available physician profile data.

Does Konstantin Kovtun, M.D. have Open Payments data?

Konstantin Kovtun, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.